These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19825523)

  • 1. No predictive value of serum interleukin-6 and transforming growth factor-beta1 in identifying patients with a first restenosis, recurrent restenosis or a history of restenosis.
    Hudzik B; Szkodzinski J; Romanowski W; Wilczek K; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
    Eur Cytokine Netw; 2009 Sep; 20(3):135-9. PubMed ID: 19825523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of interleukin-6 and transforming growth factor-beta1 in predicting restenosis within stented infarct-related artery.
    Szkodzinski J; Blazelonis A; Wilczek K; Hudzik B; Romanowski W; Gasior M; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
    Int J Immunopathol Pharmacol; 2009; 22(2):493-500. PubMed ID: 19505401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of omeprazole on the concentration of interleukin-6 and transforming growth factor-β1 in patients receiving dual antiplatelet therapy after percutaneous coronary intervention.
    Hudzik B; Szkodzinski J; Danikiewicz A; Wilczek K; Romanowski W; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
    Eur Cytokine Netw; 2010 Dec; 21(4):257-63. PubMed ID: 21084246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T29C (rs1800470) polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with restenosis after coronary stenting in Mexican patients.
    Fragoso JM; Zuñiga-Ramos J; Arellano-González M; Alvarez-León E; Villegas-Torres BE; Cruz-Lagunas A; Delgadillo-Rodriguez H; Peña-Duque MA; Martínez-Ríos MA; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):13-7. PubMed ID: 25449332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.
    Szkodzinski J; Hudzik B; Romanowski W; Wilczek K; Danikiewicz A; Gasior M; Polonski L; Zubelewicz-Szkodzinska B
    J Biol Regul Homeost Agents; 2010; 24(2):149-56. PubMed ID: 20487628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of HB-EGF and interleukin-18 are associated with a high risk of in-stent restenosis.
    Jiang H; Liu W; Liu Y; Cao F
    Anatol J Cardiol; 2015 Nov; 15(11):907-12. PubMed ID: 25868040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease.
    Schaan BD; Quadros AS; Sarmento-Leite R; De Lucca G; Bender A; Bertoluci M
    Cardiovasc Diabetol; 2007 Jul; 6():19. PubMed ID: 17651487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive liver fibrosis markers: use of serum levels of cytokines IL 1α and TGF ß1 in management of chronic liver diseases.
    Mehmedović A; Mesihović R; Prnjavorac B; Vanis N; Vukobrat-Bijedić Z; Borovac N; Zubčević N; Pilav A; Gornjaković S; Kulo-Ćesić A; Mujarić E; Saray A
    Med Glas (Zenica); 2013 Feb; 10(1):20-7. PubMed ID: 23348156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of recurrent restenosis after coronary stenting: an analysis of 197 patients.
    Kishi K; Hiasa Y; Suzuki N; Takahashi T; Hosokawa S; Tanimoto M; Otani R
    J Invasive Cardiol; 2002 Apr; 14(4):187-91. PubMed ID: 11923572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity.
    Wu HP; Chen CK; Chung K; Jiang BY; Yu TJ; Chuang DY
    J Formos Med Assoc; 2009 Jan; 108(1):20-7. PubMed ID: 19181604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D status in coronary artery disease: association with IL-35 and TGF-β1 and disease severity.
    Rasa F; Naderi N; Eftekhar E; Mansoori E; Rahimzadeh M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):522-529. PubMed ID: 29701163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum rantes, transforming growth factor-β1 and interleukin-6 levels correlate with cardiac muscle fibrosis in patients with aortic valve stenosis.
    Podolec J; Baran J; Siedlinski M; Urbanczyk M; Krupinski M; Bartus K; Niewiara L; Podolec M; Guzik T; Tomkiewicz-Pajak L; Komar M; Kablak-Ziembicka A
    J Physiol Pharmacol; 2018 Aug; 69(4):. PubMed ID: 30552305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
    Breuckmann F; Naber C; Beckert J; Schmermund A; Haude M; Baumgart D; Erbel R
    Int J Cardiol; 2006 Mar; 108(1):20-5. PubMed ID: 16516694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
    Rath D; Chatterjee M; Müller I; Müller K; Böckmann C; Droppa M; Stimpfle F; Karathanos A; Borst O; Seizer P; Langer H; Schwab M; Gawaz M; Geisler T
    Atherosclerosis; 2014 Dec; 237(2):754-9. PubMed ID: 25463116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close association of regional interleukin-6 levels in the infarct-related culprit coronary artery with restenosis in acute myocardial infarction.
    Funayama H; Ishikawa SE; Kubo N; Yasu T; Saito M; Kawakami M
    Circ J; 2006 Apr; 70(4):426-9. PubMed ID: 16565559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.
    Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE
    Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.